The stock price of Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) has dropped by -15.46 compared to previous close of 0.86. Despite this, the company has seen a fall of -20.37% in its stock price over the last five trading days. businesswire.com reported 2024-12-16 that CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics announced their PrecisionCHD and Epi+Gen CHD tests have received final pricing determinations from CMS.
Is It Worth Investing in Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) Right Now?
Additionally, the 36-month beta value for CDIO is 3.71. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CDIO is 36.50M and currently, short sellers hold a 9.53% ratio of that float. The average trading volume of CDIO on January 10, 2025 was 6.48M shares.
CDIO’s Market Performance
CDIO’s stock has seen a -20.37% decrease for the week, with a 32.76% rise in the past month and a 243.79% gain in the past quarter. The volatility ratio for the week is 15.16%, and the volatility levels for the past 30 days are at 28.69% for Cardio Diagnostics Holdings Inc. The simple moving average for the past 20 days is -26.87% for CDIO’s stock, with a 27.02% simple moving average for the past 200 days.
CDIO Trading at 22.42% from the 50-Day Moving Average
After a stumble in the market that brought CDIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.04% of loss for the given period.
Volatility was left at 28.69%, however, over the last 30 days, the volatility rate increased by 15.16%, as shares sank -6.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +227.44% upper at present.
During the last 5 trading sessions, CDIO fell by -20.37%, which changed the moving average for the period of 200-days by -47.09% in comparison to the 20-day moving average, which settled at $0.9984. In addition, Cardio Diagnostics Holdings Inc saw -20.37% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDIO starting from Philibert Robert, who purchase 34,075 shares at the price of $0.29 back on Sep 06 ’24. After this action, Philibert Robert now owns 1,683,867 shares of Cardio Diagnostics Holdings Inc, valued at $9,763 using the latest closing price.
Dogan Meeshanthini, the Chief Technology Officer of Cardio Diagnostics Holdings Inc, purchase 68,965 shares at $0.29 during a trade that took place back on Sep 06 ’24, which means that Dogan Meeshanthini is holding 197,310 shares at $20,000 based on the most recent closing price.
Stock Fundamentals for CDIO
Current profitability levels for the company are sitting at:
- -235.13 for the present operating margin
- -3.06 for the gross margin
The net margin for Cardio Diagnostics Holdings Inc stands at -231.26. The total capital return value is set at -2.01. Equity return is now at value -276.30, with -158.03 for asset returns.
Based on Cardio Diagnostics Holdings Inc (CDIO), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -22.7. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -75.18.
Currently, EBITDA for the company is -1.53 million with net debt to EBITDA at 0.16. When we switch over and look at the enterprise to sales, we see a ratio of 792.06. The receivables turnover for the company is 2.53for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.51.
Conclusion
In conclusion, Cardio Diagnostics Holdings Inc (CDIO) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
